引用本文:[点击复制]
[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 904次   下载 216 本文二维码信息
码上扫一扫!
喜炎平注射液联合特布他林、布地奈德雾化吸入治疗儿童支气管肺炎的效果及对炎症指标的影响
陈燕燕
0
(无锡市惠山区第二人民医院,江苏无锡 214174)
摘要:
目的:探讨喜炎平注射液联合特布他林、布地奈德雾化吸入治疗儿童支气管肺炎的临床疗效及对炎症指标的影响。方法:选择2014年3月至2016年3月于我院儿科病房进行治疗的支气管肺炎患儿148例,按照随机数表法分为观察组74例和对照组74例。对照组患儿给予常规治疗,观察组患儿在对照组治疗的基础上给予喜炎平注射液联合特布他林、布地奈德雾化吸入治疗。比较两组患儿临床疗效及治疗前后两组患儿降钙素原水平、C 反应蛋白水平、白细胞计数、中性粒细胞百分比。结果: 观察组临床有效率(95.95%)明显高于对照组(81.08%),差异有统计学意义(P<0.05);观察组患儿发热消失时间、咳嗽消失时间、喘息消失时间、肺部啰音消失时间、胸部X 线片炎症吸收时间、住院时间均明显短于对照组,差异有统计学意义(P<0.05)。治疗前两组患儿降钙素原水平、C反应蛋白水平、白细胞计数、中性粒细胞百分比均高于正常值,且两组比较差异无统计学意义(P>0.05);治疗后各炎性指标值均下降,观察组患儿各炎性指标水平均恢复至正常范围,且均低于对照组,差异有统计学意义 (P<0.05)。结论:喜炎平注射液联合雾化吸入可明显提高支气管肺炎患儿的治疗效果,缩短治疗时间,可明显降低炎症指标水平。
关键词:  支气管肺炎  喜炎平注射液  雾化吸入  炎症因子
DOI:10.13407/j.cnki.jpp.1672-108X.2017.08.011
基金项目:
Xiyanping Injection Combined with Terbutaline and Budesonide to Inflammatory Factors and Its Efficacy in Children with Bronchopneumonia
Chen Yanyan
(Huishan Second People's Hospital of Wuxi, Jiangsu Wuxi 214174, China)
Abstract:
Objective: To explore the affect of Xiyanping injection combined with terbutaline and budesonide atomization inhalation to inflammatory factors and its efficacy in children with bronchopneumonia. Methods: One hundred and forty-eight children with bronchopneumonia in pediatric ward of our hospital for treatment from March 2014 to March 2016 were selected, all children were divided into observation group (74 cases) and control group (74 cases). In the control group, the children were treated with conventional therapy, the observation group on the basis of the control group was given Xiyanping injection combined with terbutaline and budesonide atomization inhalation. The clinical efficacy, the levels of procalcitonin, C-reactive protein, white blood cell count, neutrophil percentage before and after the treatment were analyzed. Results: The clinical efficiency of observation group (95.95%) was significantly higher than the control group (81.08%), there was significant difference (P<0.05). The disappearance time of fever, cough, wheezing and lung rale, chest inflammation absorption time, hospitalization time of the observation group were significantly shorter than those of the control group, there were significant differences (P<0.05). Before treatment, the procalcitonin, C-reactive protein, white blood cell count, neutrophil percentage of two groups were higher than the normal value, and the two groups had no significant differences (P>0.05). After treatment, the value of the inflammatory indexes decreased under the normal value range, and the indexes of the observation group were lower than the control group, there were significant differences (P<0.05). Conclusion: Xiyanping injection combined with aerosol inhalation treatment can significantly improve the treatment of children with bronchopneumonia and shorten the time of treatment, reduce the levels of inflammatory factors significantly.
Key words:  bronchopneumonia  Xiyanping injection  atomization inhalation  inflammatory factors

用微信扫一扫

用微信扫一扫